The governors of two more U.S. states said on May 6 they were lifting most restrictions that were put in place to combat the spread of the novel coronavirus after sharp drops in infection rates and deaths.

EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, on May 6 announced key appointments across Europe to further strengthen the company’s worldwide market access and pricing solutions leadership position.

France-based Genfit launched NASHnext, a novel, non-invasive diagnostic test for nonalcoholic steatohepatitis (NASH) powered by the company’s proprietary diagnostic technology, NIS4. The test is offered in the United States through Labcorp.

Drugmakers on May 6 said U.S. President Joe Biden’s support for waiving patents of Covid-19 vaccines could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world.

Regeneron Pharmaceuticals Inc. reported a better-than-expected quarterly profit on May 6 and expects demand for the company’s Covid-19 antibody therapy to hold up even as vaccination efforts across the United States intensify.

Covid-19 has caused 6.9 million deaths globally, more than double what official numbers show, according to an analysis by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine. IHME found that Covid-19 deaths are significantly underreported in almost every country.